The painkiller propoxyphene, better known as Darvocet and Darvon, has been recalled by the Food and Drug Administration. An outside advisory panel determined that the serious and potentially fatal effects of Darvocet outweigh the pain killing properties of the drug. The FDA cited clinical studies as the primary reason for the recall. Studies found the risk of fatal heart rhythm abnormalities, risk of overdose, and high incidence of addiction were harmful consequences of Darvocet and Darvon in previously healthy patients.
Xanodyne Pharmaceutials, Inc., manufactures propoxyphene under the brand names Darvocet and Darvon. Generic alternatives to the drug have also been recalled.